Robert W. Scully - 10 Feb 2024 Form 4 Insider Report for Zoetis Inc. (ZTS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Feb 2024, 17:12:53 UTC
Prior SEC filing
12 Feb 2024
Next SEC filing
17 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Brenda Santuccio, as Attorney-in-Fact

Key filing fact

Robert W. Scully filed Form 4 for Zoetis Inc. (ZTS) on 13 Feb 2024.

Key facts

  • This page summarizes Robert W. Scully's Form 4 filing for Zoetis Inc. (ZTS).
  • 2 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 13 Feb 2024, 17:12.

Change

  • Previous filing in this sequence was filed on 12 Feb 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ZTS transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares
-1,463
Change %
-55%
Price
Shares after
1,212
Date
10 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,463
Exercise price
Footnotes
F1, F2, F3, F4, F5, F6
ZTS transaction Derivative

Deferred Stock Unit

Award

Transaction value
Shares
+1,463
Change %
+34%
Price
Shares after
5,823
Date
10 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,463
Exercise price
Footnotes
F4, F5, F9, F10, F11
ZTS holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,223
Date
10 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,223
Exercise price
Footnotes
F2, F4, F7, F8
ZTS holding Derivative

Deferred Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,890
Date
10 Feb 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
9,890
Exercise price
Footnotes
F4, F10, F12, F13
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 13 footnotes

Footnote F1

Represents restricted stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

Footnote F2

Each restricted stock unit represents a contingent right to receive one share of Zoetis Inc. common stock.

Footnote F3

Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events. The RSUs vest as follows: 1,463.3937 RSUs vested on February 10, 2024; and 1,212.3053 RSUs will vest on February 8, 2025.

Footnote F4

Not applicable.

Footnote F5

Upon the vesting of the reporting person's restricted stock units on February 10, 2024, the reporting person received 1,463.3937 deferred stock units ("DSUs") pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan. The DSUs are fully vested, accrue dividend equivalent units, and will be paid in a single lump payment within 30 business days following the earlier to occur of (i) a Termination Event, and (ii) a Change in Control that constitutes a "change in ownership or control" for purposes of Section 409A in accordance with the terms of the Plan.

Footnote F6

Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the third anniversary of the date of grant, February 8, 2022; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F7

Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").

Footnote F8

Each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first anniversary of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.

Footnote F9

Represents deferred stock units granted pursuant to a voluntary deferral under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, and dividend equivalent units automatically issued thereon (each a "DSU" and collectively, "DSUs"). The DSUs are fully vested and will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director at Zoetis.

Footnote F10

Each DSU represents the right to receive one share of Zoetis Inc. common stock.

Footnote F11

Includes 4360.0848 of DSUs previously granted under the Zoetis Inc. Amended and Restated Non-Employee Director Deferred Compensation Plan, including dividend units automatically issued thereon, and 1,463.3937 of DSUs granted upon the vesting of the Reporting Person's RSUs on February 10, 2024.

Footnote F12

Represents deferred stock units granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each a "DSU" and collectively, "DSUs"). The DSUs were fully vested on the date of the grant and will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director at Zoetis.

Footnote F13

Each DSU will be settled in shares of Zoetis Inc. common stock upon the reporting person's separation from service as a director of Zoetis Inc.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .